Home > Cashflow Statement > BIOCON

BIOCON
Cashflow Statement

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

BIOCON Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,887 Cr₹1,525 Cr₹897 Cr₹983 Cr₹1,068 Cr
Adjustment ₹1,711 Cr₹2,356 Cr₹1,685 Cr₹1,245 Cr₹710 Cr
Changes In working Capital ₹923 Cr₹-635 Cr₹-501 Cr₹-790 Cr₹-424 Cr
Cash Flow after changes in Working Capital ₹4,521 Cr₹3,246 Cr₹2,081 Cr₹1,439 Cr₹1,354 Cr
Cash Flow from Operating Activities ₹4,061 Cr₹2,954 Cr₹1,853 Cr₹1,177 Cr₹1,160 Cr
Cash Flow from Investing Activities ₹-234 Cr₹-1,005 Cr₹-14,282 Cr₹-1,699 Cr₹-3,625 Cr
Cash Flow from Financing Activities ₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr
Net Cash Inflow / Outflow ₹1,973 Cr₹-383 Cr₹619 Cr₹-280 Cr₹99 Cr
Opening Cash & Cash Equivalents ₹920 Cr₹1,300 Cr₹654 Cr₹897 Cr₹825 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---₹34 Cr₹-34 Cr
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹31 Cr₹2.90 Cr₹22 Cr₹3.30 Cr₹7.10 Cr
Closing Cash & Cash Equivalent ₹2,924 Cr₹920 Cr₹1,295 Cr₹654 Cr₹897 Cr

Compare Cashflow Statement of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹56,504.6 Cr -1.8% -10.6% 0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.8%

-10.6%

0.1%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses